AbbVie and Intouch Solutions
Creon CFCareForward RM Campaign Experience
About 90% of cystic fibrosis patients also have Exocrine Pancreatic Insufficiency, yet treatment is often overshadowed by the focus on lung health. To overcome that, Creon’s easy-to-understand materials and masterful segmentation are raising educational levels and boosting retention, shifting the paradigm from “I take my enzymes” to “I manage my enzymes.” The first email touch boasted a 72% open rate.
